Media

Press Release

BREAKING NEWS RELEASE

Zoo Pharma Dynamics Partners with Pivotal Feeds to Enhance Animal Health with Innovative Forage Solutions

SAN ANTONIO, TX — February 26, 2025 –

Zoo Pharma Dynamics (ZPD) is entering a strategic partnership with Pivotal Feeds, based in Dell City, Texas. This collaboration aims to combine ZPD's groundbreaking additive technology with Pivotal Feeds' flagship product, Chaffhaye, to significantly improve animal health across multiple species.

Chaffhaye, a high-quality forage marketed by Pivotal Feeds, has been recognized as an optimal feed for a variety of animal species, including corvids, equines, goats, camelids, and chickens. Brian Kanke, president of Zoo Pharma Dynamics, has been advocating for Chaffhaye for over 20 years, stating, “There is no better forage for an animal.”

Educational support is a cornerstone of Pivotal Feeds' mission, as they strive to ensure that customers maximize the benefits of Chaffhaye. This partnership will further advance the educational resources available to enhance understanding of the product's unique advantages.

ZPD has developed the Cervid Prion Preventative (CPP) as part of its ongoing efforts to combat Chronic Wasting Disease (CWD). Currently undergoing field trials in preparation for the FDA/CVM drug approval process, CPP has shown efficacy when incorporated into various formats, including pellets, protein blocks, and water-soluble supplements. By integrating CPP with Chaffhaye, ZPD believes they can enhance its effectiveness and provide significant health benefits to the animals consuming it.

At ZPD’s South Texas Research Facility, the team has been successfully mixing CPP with Chaffhaye for field trial purposes. Preliminary data indicates promising results regarding formulation compatibility and safety. Notably, there's been an increase in Chaffhaye consumption among cervids when the additive is included.

Danny Heredia, president of Pivotal Feeds, expressed enthusiasm for the collaboration: “We are thrilled to join forces with ZPD in this exciting initiative. By merging our expertise, we aim to provide deer farmers with innovative solutions that enhance animal health and productivity.”

The partnership will see the first production of Chaffhaye with the CPP additive in late April to early May 2025, coinciding with the first harvest of the growing season. ZPD and Pivotal Feeds will work closely with the North American Deer Farmer Association (NADeFA) to identify participating deer farms for field trials and share findings with the membership community.

“This collaboration not only underscores our commitment to the health of the animals we serve but also to the education of those in the farming community,” added Kanke. “Together, we aim to deliver the best possible outcomes and advance knowledge within the sector.”

As a leader in pharmacognosy research and development, Zoo Pharma Dynamics is dedicated to keeping animals healthy through innovative research and the development of animal healthcare products. ZPD works with some of the best veterinarians, scientists, and researchers around the world to find solutions that optimize animal healthcare.

CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS
The information contained in this publication does not constitute an offer to sell or solicit an offer to buy securities of Zoo Pharma Dynamics, Inc. (the “Company”). This publication contains forward-looking statements, which are not guarantees of future performance and may involve subjective judgment and analysis. The information provided herein is believed to be accurate and reliable, however the Company makes no representations or warranties, expressed or implied, as to its accuracy or completeness. The Company has no obligation to provide the recipient with additional updated information. No information in this publication should be interpreted as any indication whatsoever of the Company’s future revenues, results of operations, or stock price.

###

_________________________________________________

Zoo Pharma Dynamics to Engage North American Deer Farmers Association in EHD Prevention Trials

SAN ANTONIO, TX - February 11, 2025 – Zoo Pharma Dynamics (ZPD) will initiate its third round of field trials focused on the prevention of Epizootic Hemorrhagic Disease (EHD) in collaboration with the North American Deer Farmers Association (NADeFA).

The trials, slated to begin in May 2025 and run through August 2025, will involve ZPD selecting five deer farms, as identified by NADeFA, to participate in this significant research effort.

ZPD will administer a top-dress pellet supplement designed to repel the midge fly, the primary vector of EHD. It is important to note that this supplement acts as a repellent rather than a cure. The inclusion of NADeFA in these trials provides valuable opportunities for its members to actively engage in research and share collected data within the association.

There is no financial obligation for either NADeFA or the participating deer farms involved in the trials. ZPD is dedicated to building comprehensive data sets essential for its FDA/CVM approval process.

"We are excited to partner with NADEFA for these crucial field trials," said Brian Kanke, president of ZPD. "This collaboration not only empowers deer farmers with firsthand experience in EHD prevention but also contributes to our understanding of how to combat the disease that poses a significant threat to deer populations."

Zoo Pharma Dynamics is a pharmacognosy research and development company dedicated to keeping animals healthy through innovative research and the development of animal healthcare products. ZPD works with some of the best veterinarians, scientists, and researchers around the world to find solutions to optimize animal healthcare.

CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS

The information contained in this publication does not constitute an offer to sell or solicit an offer to buy securities of Zoo Pharma Dynamics, Inc. (the “Company”). This publication contains forward-looking statements, which are not guarantees of future performance and may involve subjective judgment and analysis. The information provided herein is believed to be accurate and reliable, however the Company makes no representations or warranties, expressed or implied, as to its accuracy or completeness. The Company has no obligation to provide the recipient with additional updated information. No information in this publication should be interpreted as any indication whatsoever of the Company’s future revenues, results of operations, or stock price.

###

_________________________________________________

ZPD Launches Pioneering Field Trial to Combat Johne’s Disease in Livestock

SAN ANTONIO, TX - February 6, 2025 – Zoo Pharma Dynamics (ZPD) has launched a field study in Oklahoma to evaluate the delivery of an innovative oral treatment for Johne’s Disease. In conjunction with its industry partners, ZPD seeks to analyze the data gathered during this trial to determine the effectiveness of the treatment and to enhance its formulations. This collaborative effort aims to develop a future tool that could protect wildlife, livestock, and the public from the impacts of this disease.

Johne's Disease, also referred to as paratuberculosis, is a chronic bacterial infection that primarily affects the intestines of ruminant animals including cattle, sheep, goats, camelids, and cervids. The disease is caused by the bacterium Mycobacterium avium subspecies paratuberculosis, which is shed in the feces of infected animals and can contaminate the environment, feed, and water. Infection can occur through contact with these contaminated materials.

With a long incubation period that can extend for years, symptoms of Johne’s Disease include severe diarrhea, emaciation, and fever, which often leads to dehydration and further health complications.

“Utilizing insights gained from our previous research and development efforts with other diseases, we are optimistic that we have identified a promising treatment pathway for Johne’s Disease,” said Brian Kanke, president of Zoo Pharma Dynamics. “By combining specific active ingredients from our prior formulations, we are working towards a solution that effectively targets the disease while maintaining the health of the animal. The initial results are encouraging, and we look forward to sharing our findings with the scientific community.”

During the field trial, ZPD will follow established protocols for the collection of initial data through blood, tissue, and fecal samples, assessing any further sampling needs as the study progresses. A thorough evaluation of this initial trial will be conducted prior to proceeding with any subsequent trials, ensuring that all data aligns with scientific standards.

Zoo Pharma Dynamics is a pharmacognosy research and development company dedicated to keeping animals healthy through innovative research and the development of animal healthcare products. ZPD works with some of the best veterinarians, scientists, and researchers around the world to find solutions to optimize animal healthcare.

CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTS

The information contained in this publication does not constitute an offer to sell or solicit an offer to buy securities of Zoo Pharma Dynamics, Inc. (the “Company”). This publication contains forward-looking statements, which are not guarantees of future performance and may involve subjective judgment and analysis. The information provided herein is believed to be accurate and reliable, however the Company makes no representations or warranties, expressed or implied, as to its accuracy or completeness. The Company has no obligation to provide the recipient with additional updated information. No information in this publication should be interpreted as any indication whatsoever of the Company’s future revenues, results of operations, or stock price.

###

_________________________________________________

Zoo Pharma Dynamics Takes Major Leaps in Battle Against Epizootic Hemorrhagic Disease (EHD)

SAN ANTONIO, TX - January 10, 2025 – Zoo Pharma Dynamics is proud to announce significant advancements in the fight against Epizootic Hemorrhagic Disease (EHD), one of the deadliest viruses affecting deer populations. Our research and development efforts, bolstered by strategic collaborations, are critical to the success of our innovative formulation and application processes.

Central to our approach is the introduction of the post-pellet liquid application (PPLA) system. This specialized spray technology ensures an even distribution of our liquid additive on the pellets, which enhances the availability and efficacy of the treatment. The PPLA method effectively eliminates any risk of heat sensitivity during the pelleting process, preserving the integrity of the additive throughout.

"We are committed to finding solutions that protect wildlife and the ecosystems they inhabit,” said Brian Kanke, President of Zoo Pharma Dynamics. “Collaborating with our strategic partners and advancing our research is crucial not only for the success of our current formulation but also for the future of deer health management.”

Ongoing field trials are currently taking place at our research center and lab, with plans for additional trials set for this spring. As warmer weather returns and midge flies, along with other insects, become more prevalent, these trials will facilitate the testing of cervid fluids and hair follicle samples for the new additive.

Zoo Pharma Dynamics invites interested parties to participate in our upcoming field trials. To get involved and for more information, please visit our website at www.zoopharmadynamics.com and fill out the field trial application.

Zoo Pharma Dynamics is a pharmacognosy research and development company dedicated to keeping animals healthy through innovative research and the development of animal healthcare products. ZPD works with some of the best veterinarians, scientists, and researchers around the world to find solutions to optimize animal healthcare.

###

_________________________________________________

Zoo Pharma Dynamics to Launch New Division “MAKA Bioscience” to Bridge Animal and Human Health Initiatives

SAN ANTONIO, TX - November 26, 2024 – Zoo Pharma Dynamics (ZPD) is pleased to announce the establishment of a new division, "MAKA Bioscience," effective January 1, 2025. This strategic initiative aims to broaden ZPD’s operations and fully utilize its robust research and development capabilities to address a vital additional market: human health.

The foundation of this new division emphasizes the natural synergy between ZPD’s expertise in animal health and MAKA Bioscience’s focus on human health. Our extensive areas of research and development are anticipated to complement both operations seamlessly. As the understanding of the connection between human and animal health grows, it becomes clear that addressing these intertwined issues is essential for effective healthcare solutions.

Brian Kanke, President of Zoo Pharma Dynamics, said, “The launch of MAKA Bioscience marks an exciting new chapter for our organization. By expanding our operations to focus on human health, we are maximizing our research potential. ZPD’s current work on Prion Disease will provide a critical foundation for MAKA as it delves into human health research, particularly in relation to Tau Protein. Together, we can make significant strides in addressing the diseases that affect both human and animal populations.”

ZPD is committed to delivering its research on Prion Disease to MAKA Bioscience, enabling further exploration and development of novel human health solutions. In addition, MAKA Bioscience plans to target various facets of human health while actively seeking strategic partnerships starting in early 2025. This collaboration underscores the critical role that animal health plays in human health, given our shared susceptibility to numerous diseases and the essential role animals have in treatments and cures. As ZPD expands into this new arena, the potential for groundbreaking research and innovations increases significantly.

Zoo Pharma Dynamics is a pharmacognosy research and development company dedicated to keeping animals healthy through innovative research and the development of animal healthcare products. ZPD works with some of the best veterinarians, scientists, and researchers around the world to find solutions to optimize animal healthcare.

###

_________________________________________________

Zoo Pharma Dynamics Partners with Element to Combat EHD in Cervids with Innovative Feed Additive

SAN ANTONIO, TX - November 4, 2024 – Zoo Pharma Dynamics (ZPD) is excited to announce a groundbreaking partnership with Element to advance field trials of a revolutionary feed additive designed to repel the midge fly, a primary vector of Epizootic Hemorrhagic Disease (EHD) in Cervids. After six years of dedicated research and development, ZPD's mid-stage trials have yielded promising results, paving the way for significant advancements in the fight against this deadly disease.

EHD has emerged as the leading cause of mortality in Cervids, with fatalities surpassing those caused by any other disease. The innovative feed additive not only provides a safeguard against midge fly infestation but also shows efficacy in repelling various other insects, including barn flies, ants, house flies, and ticks. Notably, the additive is palatable and has demonstrated no adverse effects on Cervid health.

"Our commitment to understanding and combating EHD has never wavered," said Brian Kanke, President of Zoo Pharma Dynamics. "The partnership with Element represents a significant step forward in our mission. Our research has uncovered an additive that not only protects Cervids from the midge fly but is also safe and beneficial for their health. This could be a game-changer for Cervid populations facing the dire consequences of EHD."

Furthermore, ZPD is examining how the substance is secreted through the animal’s digestive process, with positive indications of its presence in hair, sweat, saliva, nasal fluids, urine, and manure. This suggests that the feed additive may have even greater potential as a long-lasting repellent.

As part of our collaborative efforts with Element, we are committed to refining this formulation to maximize its effectiveness against EHD, thereby ensuring a sustainable solution for the health and survival of Cervid populations.

Zoo Pharma Dynamics is a pharmacognosy research and development company dedicated to keeping animals healthy through innovative research and the development of animal healthcare products. ZPD works with some of the best veterinarians, scientists, and researchers around the world to find solutions to optimize animal healthcare. For media inquiries or more information, please contact Brian Kanke at (830) 444-2030 or email brian@zoopharmadynamics.com or visit www.zoopharmadynamics.com.

Note to Editors: Epizootic Hemorrhagic Disease (EHD) is a serious viral disease affecting deer populations that can have significant ecological and economic impacts.

###

_________________________________________________

Zoo Pharma Dynamics, Inc. (ZPD) Launches New Program to Support Veterans with Therapy and Career Challenges

SAN ANTONIO, TX - October 8, 2024 – Zoo Pharma Dynamics, Inc. (ZPD) has announced a commitment to assist Veterans facing therapy and career challenges through a new program developed in collaboration with its internal entity, Cervid Breeders Institute (CBI). This innovative initiative invites Veterans interested in Ranch Management and Animal Healthcare to engage at ZPD’s South Texas Research Facility located in Yancey, Texas.

To effectively reach those in need, ZPD will partner with local American Legion Posts to identify Veterans seeking assistance and keen to learn the intricacies of ranch operations and animal care.

The President of ZPD has been actively involved in various programs that underscore the therapeutic benefits of animal interaction, emphasizing how these experiences can restore purpose to individuals in need. The new program will feature a combination of classroom training, hands-on field experiences, and active participation in the operations of ZPD's research facilities. The primary goal of this initiative is to foster mental and physical healing among Veterans, creating new career opportunities in an industry that promises to be beneficial for their future. Upon completion of the program, ZPD will assist Veterans in securing employment within its extensive network of businesses.

"At ZPD, we believe in the power of reintegration and healing through hands-on experiences. Our new program not only provides valuable skills in ranch management and animal healthcare but also aims to promote personal growth and rehabilitation. We are dedicated to supporting our Veterans and helping them find their path forward in life,” said Brian Kanke, President of Zoo Pharma Dynamics, Inc.

The inaugural program is slated to commence on November 1, 2024.

###

_________________________________________________

Zoo Pharma Dynamics Announces Production of Custom Nutritional Supplements with State-of-the-Art Pellet Mills

SAN ANTONIO, TX - September 23, 2024 – Zoo Pharma Dynamics (ZPD) is pleased to announce the operational launch of its state-of-the-art pellet mills, a significant advancement that enables the production of a diverse range of high-quality nutritional supplements tailored specifically for various farming operations. These innovative systems allow for customizable nutrition pellet solutions, catering to the unique needs of farms of any size while ensuring complete control over inputs and superior quality outputs.

The advanced pellet mills operate at lower temperatures, effectively preserving essential nutrients and enzymes, which guarantees consistent quality across every pellet produced. ZPD is now equipped to manufacture feed pellets in various sizes suitable for a wide array of livestock, including, deer, cattle, horses, and poultry. Unlike traditional pellet production methods that rely on liquid nitrogen for cooling, our mills are engineered for high torque and low RPMs, significantly reducing heat generation and enhancing nutrient preservation.

"Our new pellet mills empower us to produce high-quality nutritional supplements designed for diverse farming operations," said Brian Kanke, President of Zoo Pharma Dynamics. "These innovative systems not only allow for customizable nutrition but also ensure the integrity of essential nutrients through low-temperature processes. Our commitment to superior outputs positions us to support farm operations of any size with tailored solutions. We are proud to offer a variety of products under our FARM brand, all designed with convenience and sustainability in mind."

Zoo Pharma Dynamics is currently offering several products under its FARM brand, including Kelp Pellets, Kelp Plus, VM Crumbles, and Power OX. Each product is packaged in reusable plastic buckets with airtight lids, emphasizing both convenience and sustainable practices.

For more information about our products and how they can enhance your farming operations, please visit www.zpddistribution.com.

Zoo Pharma Dynamics is a pharmacognosy research and development company dedicated to keeping animals healthy through innovative research and the development of animal healthcare products. ZPD works with some of the best veterinarians, scientists, and researchers around the world to find solutions to optimize animal healthcare.

###

_________________________________________________

Zoo Pharma Dynamics Attends Key Industry Event, Strengthening Partnerships and Showcasing Innovation

SAN ANTONIO, TX - August 1, 2024 – Zoo Pharma Dynamics (ZPD) proudly announced its successful participation in the recent 6th Animal Health, Nutrition and Technology Innovation USA held in Boston, MA where it sponsored an exhibit booth and engaged in a series of valuable roundtable discussions. As a forward-thinking leader in the animal healthcare industry, ZPD continues to emphasize the significance of staying abreast of technological advancements while building strategic partnerships.

"Our participation in this event is crucial for our mission to remain at the forefront of new technologies and to enhance our networking capabilities," said Brian Kanke, President of Zoo Pharma Dynamics. He further added, "It's better to traverse into the unknown instead of never finding out what's there. For a business to be successful, you must partner with those smarter than you."

During the event, ZPD showcased its latest research and products at its exhibit booth, facilitating one-on-one interactions with industry peers. The company also had the privilege of presenting its journey through the FDA processes at a roundtable discussion, highlighting key insights and experiences that resonate with fellow professionals in the field.

One of the notable outcomes from attending the event was the formation of a strategic partnership with a global company that will provide support in addressing third-party laboratory and regulatory issues. “This partnership positions us to enhance our operational efficiency and aligns seamlessly with our business objectives," Kanke stated.

Looking ahead, Zoo Pharma Dynamics is eager to implement insights gained from the event to solidify its reputation as a thought leader in the animal healthcare / research and development space. The company is committed to ongoing participation in similar events, recognizing them as vital to fostering innovation and maintaining a competitive edge in the industry.

Zoo Pharma Dynamics is a pharmacognosy research and development company dedicated to keeping animals healthy through innovative research and the development of animal healthcare products. ZPD works with some of the best veterinarians, scientists, and researchers around the world to find solutions to optimize animal healthcare.

###

___________________________________________________________

Zoo Pharma Dynamics Launches Additional Field Trial Programs
To Protect Against Chronic Wasting Disease

SAN ANTONIO, TX - November 1, 2023 – Zoo Pharma Dynamics, a leading pharmacognosy company specializing in animal health, is adding three more field trials to its existing program in combating Chronic Wasting Disease (CWD). With a rich history of conducting field trials, the company's latest program marks a significant milestone in the relentless battle against this debilitating disease that impacts cervides.

“Chronic Wasting Disease has garnered increased attention in recent years due to its detrimental impact on wildlife conservation efforts and the negative economic impact on land owners, and breeders. Zoo Pharma Dynamics (ZPD) recognizes the urgency of addressing this issue and has committed itself to developing an innovative solution that can effectively combat the spread of CWD across affected regions,” said Brian Kanke president of ZPD.

The field trial program, a crucial step in evaluating the efficacy of ZPD’s novel preventive approach, will commence on an additional three ranches that are heavily impacted by CWD. This program will involve close collaboration with local wildlife authorities, veterinary experts, and stakeholders to ensure comprehensive data collection and analysis. By conducting these trials, Zoo Pharma Dynamics aims to gather valuable insights that will enable the refinement and optimization of their solution.

"We are thrilled to to be conducting more field trials, taking us one step closer to overcoming Chronic Wasting Disease," stated Kanke. "This initiative serves as a testament to our company's commitment to animal health, conservation, and developing innovative solutions to combat emerging challenges."

Zoo Pharma Dynamics' preventive approach against CWD encompasses the application of cutting-edge technology and rigorous research. The company's team of experienced scientists and veterinarians have been tirelessly working to develop a promising solution that targets the root causes of the disease, aiming for long-lasting protection against its devastating consequences. By preventing further transmission within animal populations, Zoo Pharma Dynamics hopes to contribute significantly to the preservation of affected ecosystems.

“The field trial program marks an important milestone in Zoo Pharma Dynamics' mission to tackle Chronic Wasting Disease head-on and offers renewed hope to wildlife populations affected by this relentless prion disorder. The company remains committed to sharing updates and progress made during these trials with the scientific community, conservation organizations, and the public at large,” Kanke said.

Interested parties are encouraged to get in touch with ZPD, as they are available to discuss and address this crucial situation. For media inquiries or more information, reach out to Brian Kanke at (830) 444-2030 or email brian@zoopharmadynamics.com. Alternatively, you can visit www.zoopharmadynamics.com.

###

_____________________________________________________

Zoo Pharma Dynamics Takes on the Fight Against Chronic Wasting Disease (CWD) to Preserve Hunting Heritage and Deer Breeding Industry

SAN ANTONIO, TX - September 8, 2023 – Chronic Wasting Disease (CWD) continues to affect multiple states with varying severity levels, and the implementation of stricter state-mandated measures. In an effort to address this growing concern, Zoo Pharma Dynamics (ZPD) is actively leading the charge in finding a solution.

Back in November 2021, ZPD initiated an interaction with the Food and Drug Administration’s Center for Veterinary Medicine (FDA/CVM) by opening an Investigational New Animal Drug (INAD) file, with an indication to prevent and cure Chronic Wasting Disease.

In July 2023, Brian Kanke, the President of Zoo Pharma Dynamics, had a highly successful face-to-face meeting with the FDA/CVM at their office in Maryland. The purpose of the meeting was to discuss Zoo Pharma's intention to Achieve Conditional Approval, also known as CNADA, in order to expedite the availability of their product.

Various team leaders within the CVM team showed interest in the product offered by Zoo Pharma Dynamics. One of the options that were discussed involved the potential facilitation of a meeting between ZPD and state agencies to explain that having an INAD file and meeting certain requirements allows for ZPD to use the drug in investigations while under review.

"The journey has been both arduous and tremendously fulfilling, and I am thrilled at the prospect of engaging with state agencies to evaluate our field trial process," expressed Kanke.

Founded in 2009 and officially incorporated in 2019, ZPD has made significant strides in its research and development efforts each year. Thanks to their self-funding; ZPD has actively explored every viable path available in their ongoing research.

"As a dedicated deer breeder in South Texas, alongside our partners, we have experienced the consequences facing our industry. However, we have chosen a different approach – investing in finding a solution. We encourage all stakeholders to join us for the right reasons and reach out to us for collaboration," said Kanke.

Their commitment to finding a solution was further reinforced when Kanke witnessed the destructive impact of CWD firsthand.

"One of our ZPD partners, involved in a separate partnership, endured the loss of a multimillion-dollar deer operation. However, ZPD intervened, bringing an end to the madness and delivering closure to this terrible event," said Kanke.

Kanke emphasized the importance of avoiding the tendency to attribute the spread of Chronic Wasting Disease to a single cause. He believes that assigning blame without considering all the factors involved is counterproductive.

"Testing for this disease is a relatively recent development, and certain specific groups have been at the forefront in carrying out tests because of the straightforwardness of the process," stated Kanke. "Being at the forefront of testing does not imply any responsibility for the origin or spread of the disease. Making such claims would be scientifically unethical."

Kanke argued that we should prevent politics from adversely affecting an industry that is highly valued by many and has been passed down through generations as a cherished hunting tradition.

Zoo Pharma Dynamics is dedicated to bringing hope and preserving the industry for the countless individuals who enjoy it. We encourage interested parties to reach out, as ZPD remain available to discuss and address this critical situation. For media inquiries or more information, please contact Brian Kanke at (830) 444-2030 or email brian@zoopharmadynamics.com or visit www.zoopharmadynamics.com.

Zoo Pharma Dynamics is a pharmacognosy research and development company dedicated to keeping animals healthy through innovative research and the development of animal healthcare products. ZPD works with some of the best veterinarians, scientists, and researchers around the world to find solutions to optimize animal healthcare.

###

_____________________________________________________

Zoo Pharma Dynamics Rises to Prominence at Animal Health Conference, Leading the Fight Against Zoonotic Diseases
with Game-Changing Innovations

SAN ANTONIO, TX - June 28, 2023 – Zoo Pharma Dynamics, an up and coming player in the animal health industry, recently made a significant mark at the highly anticipated Animal Health, Nutrition & Technology Innovation conference in Boston, MA.

With its cutting-edge research and innovative solutions, ZPD showcased its dedication to advancing animal health and nutrition by leading a roundtable discussion on Zoonotic diseases with an emphasis on Chronic Wasting Disease at the conference held June 11-14, 2023.

“Attending the event was a strategic move, enabling the company to network with industry experts and leaders, showcasing our latest advancements, and pave the way for future collaborations that embody our commitment to transform and revolutionize the animal health sphere,” said Brian Kanke, President of Zoo Pharma Dynamics.

ZPD was highly unique at the event, distinguishing itself as the only research and development company that focuses explicitly on Zoonotic Diseases from both a wildlife and production animal perspective. This distinctive approach garnered significant attention and admiration from industry professionals and attendees.

The company's dedication, and initiatives have positioned it as a front runner in the ongoing battle against Chronic Wasting Disease, paving the way for transformative advancements in animal healthcare on a global scale.

Zoo Pharma Dynamics would like to express its sincere appreciation to the following individuals for their valuable time and contributions during the meetings and round table discussions:

Adriann Sax, CEO, Vetigenics
Amber Oerly, Senior Analyst, Fulcrum Global Capital
Dorina Buehrle, CEO, Piavita
Gary Jennings, CEO, Saiba Animal Health AG
Helen Cao, President, Innovhope Inc.
Jean Macklaim, PM, Diversigen
Jeff Santosuosso, Senior Consultant, Brakke Consulting
Jenna Mutch, VP, Butterfly Network
Laura Kurth, VP, MLM Labs
Robert Nordgren, MP, Covenant Animal Health Partners
Sam Tapia, SP, Prelude
Sarah Chatterjee, GM, Syngene USA, Inc.
Pengcheng Xue, AD, Innovhope Inc.
Chris Kelly, MP, Antelligence
Sanjeev Anand, CBO, Modulant Biosciences
Allan Xue, AD, Innovhope Inc.
Tom Overbay, CEO, Covenant Animal Health Partners
Sian Lazell, SA, S&P Global Animal Health
Robert Jones, President, Brakke Consulting
Johnathan Hare, Director, Clinglobal
Emmitt Nantz, CEO, Inventory Ally

Their participation, insights and expertise have been instrumental in enriching our discussions and advancing our goals. Thank you to all the attendees for your invaluable contributions.

###

_____________________________________________________

Zoo Pharma Dynamics To Present At Animal Health, Nutrition & Technology Innovation Conference

SAN ANTONIO, TX - May 9, 2023 – Zoo Pharma Dynamics, Inc (ZPD) will be presenting at the 2023 Animal Health, Nutrition & Technology Innovation Conference in Boston, MA. The conference held June 12-14, 2023, is a unique opportunity for ZPD to be in front of the industry’s most influential figures, investors and scientists.

ZPD will lead a roundtable discussion on "Zoonotic Animal Healthcare Covering Prevention and Treatment of Diseases in Wildlife and Production Animals.'

“This is a an extremely exciting time for Zoo Pharma Dynamics, our research and development will be the focus as we lead a round table discussion on "Zoonotic Animal Health Care Covering Wildlife and Production Animals," said Brian Kanke, president of Zoo Pharma Dynamics.

Scientists, innovators and many CEOs of animal health companies from around the world will be attending the symposium.

Zoo Pharma Dynamics is a pharmacognosy research & development company dedicated to keeping animals healthy through innovative research and development of animal healthcare products. ZPD works with some of the best veterinarians, scientist and researchers around the world to find solutions to optimize animal healthcare.

###

_____________________________________________________

ZPD Enters Exploratory Partnership With Bio Initiative

SAN ANTONIO, TX - April 28, 2023 – Zoo Pharma Dynamics (ZPD) is in an exploratory partnership with Dr. Dennis Morris MD, of the BIO Initiative, which involves Bio Defense. The area of focus will be Chronic Wasting Disease (CWD) Mitigation through a pre-determined triangulation from Louisiana, Mississippi and Texas.

The focus coincides with ZPD’s efforts to eliminate the prion disease that causes CWD. Dr. Morris is an expert in his field as a neurologist and has a complete understanding of prion disease. Zoo Pharma Dynamics is prepared to be an integral part of the research and future developments that arise from this joint effort to eradicate and control prion disease. Future press releases will provide the exact methods we will use to implement Bio defense in correlation with ZPD’s efforts to fight against the prion disease that causes CWD.

Zoo Pharma Dynamics has a complete deer breeding operation comprised of several species. We have the ability to control the research environment to the desired level for a particular project. ZPD has a solid base of industry partners to assist at all phases of your project. All projects will be handled confidentially with Non Disclosure Agreements in effect. We have several options to help in the costs associated with our services. Let ZPD’s years of experience go to work for you; we understand the process and remember how we got started.

###

_____________________________________________________

Research and Development Opportunities For Entrepreneurs

SAN ANTONIO, TX - March 14, 2023 – Zoo Pharma Dynamics, Inc is expanding its services. ZPD is opening research and development to entrepreneurs to assist in gathering the data needed to take their animal nutrition idea to the next level. We can assist at any level; from idea, to formulation, to field trials and the collection of data to support the claims made. We specialize in hoofed animals with an emphasis on Cervids. The ZPD team will review any project and provide the best case scenario for success.

New Product Development

Our team will support your Research and Development projects through small scale manufacturing and gathering data from real time solutions.

Nutritional Supplements

We can test your products on site to specific animals to verify that your finished supplement meets the intended specifications.

Proof of Concept Projects

Keeping your project moving forward is one of our top priorities. Let us assist in the collection of reliable data to support the claims of new products and ideas.

Zoo Pharma Dynamics has a complete deer breeding operation comprised of several species. We have the ability to control the research environment to the desired level for a particular project. ZPD has a solid base of industry partners to assist at all phases of your project. All projects will be handled confidentially with Non Disclosure Agreements in effect. We have several options to help in the costs associated with our services. Let ZPD’s years of experience go to work for you; we understand the process and remember how we got started.

###

If you would like more information about this topic, please contact Brian Kanke at brian@zoopharmadynamics.com or visit www.zoopharmadynamics.com.

_____________________________________________________

International Animal Health Consulting Firm Partners With ZPD

SAN ANTONIO, TX - Jan 4, 2023 – Zoo Pharma Dynamics has entered into a consulting partnership with Brakke Consulting.

Brakke Consulting is the leading consulting firm in the animal health and nutrition industries: companion animals, farm animals, and the veterinary industry that serves them. No other animal health-consulting firm can match their team of senior-level executive insiders, internal market research expertise, or their track record of more than 35 years of consulting at the heart of the industry.

"We are pleased to partner with Brakke Consulting on this important work during a time of unprecedented challenges in the cervid industry," said Brian Kanke, president of Zoo Pharma Dynamics. "Given this critical need, ZPD and Brakke will continue to develop and prioritize resources dedicated to supporting the well being of cervids being affected by chronic wasting disease"

Brakke will be mentoring operations, FDA processes and the marketing of ZPD portfolio of products to manufacturers.

###

If you would like more information about this topic, please contact Brian Kanke at brian@zoopharmadynamics.com or visit www.zoopharmadynamics.com.

_____________________________________________________

Certified Breeders Institute - Spring 2023

SAN ANTONIO, TX - Oct 25, 2022 – Zoo Pharma Dynamics (ZPD) is happy to announce the opening of the Cervid Breeders Institute, “CBI,” in the Spring of 2023. We will have a special opening prior to actual opening for select guests. We will focus on the challenges, solutions, and the rewards of the Cervid Breeding Industry. The course will consist of real time situations and a hands-on approach. The course will last 3 days with lodging and meals provided at our South Texas Research Facility.

Areas of Focus

• Introduction To ZPD

• Breeding Business Model

• Rules and Regulations

• Supporting TPWD

• Pen Management

• Why Natural Matters

• Animal Husbandry

• Parasites and Diseases

• Preventative Measures

• ZPD Research and Development

• Q & A Open Discussion

We are very excited to share our research and development as well as providing industry experts as guest speakers. Please sign up for our newsletter at www.ZooPharmaDynamics.com.

Zoo Pharma Dynamics is a pharmacognosy research & development company dedicated to keeping animals healthy through innovative research and development of animal healthcare products. ZPD works with some of the best veterinarians, scientist and researchers around the world to find solutions to optimize animal healthcare.

###

If you would like more information about this topic, please contact Brian Kanke at brian@zoopharmadynamics.com or visit www.zoopharmadynamics.com.

_____________________________________________________

Major Milestone: Zoo Pharma Dynamics Successfully Fights CWD

SAN ANTONIO, TX - Sept 29, 2022 — Zoo Pharma Dynamics (ZPD) has 4 products to help fight the prion disease that causes Chronic Wasting Disease (CWD). We have been doing field trials for over 8 years. After the winter storm in Texas in 2021 there was increase of whitetail deer postmortem CWD samples being sent to Texas A&M Veterinary Medical Diagnostic Laboratory (TVMDL) in early spring and some large breeding operations had CWD positives in their herds. This caused hundreds of ranches and facilities to go under quarantine for further testing.

Zoo Pharma Dynamics set up a field trial on a whitetail deer breeding facility with known positives in the herd. We assessed the situation and examined the timeframe we would have to conduct the field trial. We were limited on the number of days we would be able to conduct the field trial due to regulations and instructions being given regarding the white tail deer in the facility. We reformulated one of our products with some minor modifications to increase its strength and reaction time to attack the prion disease. The field trial lasted approximately 3 weeks. The white tail deer in the facility were all treated with PWP which contains CPP. The whitetail deer were all sent to TVMDL for postmortem testing for CWD. All deer in the field trial tested negative for CWD.

Zoo Pharma Dynamics is a pharmacognosy research & development company dedicated to keeping animals healthy through innovative research and development of animal healthcare products. ZPD works with some of the best veterinarians, scientist and researchers around the world to find solutions to optimize animal healthcare.

###

If you would like more information about this topic, please contact Brian Kanke at brian@zoopharmadynamics.com or visit www.zoopharmadynamics.com.

_____________________________________________________

Zoo Pharma Dynamics Submits For FDA Approval

SAN ANTONIO, TX - March 9, 2022 — Zoo Pharma Dynamics (ZPD) and its Cervid Preventative Product, "CPP" have been submitted to the Food and Drug Administration (FDA) for approval. ZPD has been conducting research and development to find a solution to fight against the Prion Disease that causes Chronic Wasting Disease (CWD) for more than 10 years.

“At Zoo Pharma Dynamics our goal is to find a solution to CWD, and we are working diligently in getting our product approved by the FDA,“ said Brian Kanke, Chairman of Zoo Pharma Dynamics.

Zoo Pharma Dynamics is a pharmacognosy research & development company dedicated to keeping animals healthy through innovative research and development of animal healthcare products. ZPD works with some of the best veterinarians, scientist and researchers around the world to find solutions to optimize animal healthcare.

###

If you would like more information about this topic, please contact Brian Kanke at brian@zoopharmadynamics.com or visit www.zoopharmadynamics.com.

_____________________________________________________

Natural Extracts Key To Zoo Pharma Dynamics Formula

SAN ANTONIO, TX - April 22, 2021 — Zoo Pharma Dynamics fight against Prion Disease that causes Chronic Wasting Disease (CWD) incorporates natural extracts into its formulation. The active ingredients used in our research and field trial testing program is "CPP" and is formulated with the extracts of three lichens which can produce lichen protease in the gastrointestinal tract of a Cervid.

This process creates a higher acidic level which increases the PH levels which can have the ability to push prions out of the danger zone. CPP has added a formulation of Copper to help prevent the Prion protein to take up manganese and unfold, while keeping sulfur at a minimum level. ZPD is continuing to develop and test these formulations and more testing is needed. ZPD is actively seeking more participants for the Field Trials.

Zoo Pharma Dynamics is a pharmacognosy research & development company dedicated to keeping animals healthy through innovative research and development of animal healthcare products. ZPD works with some of the best veterinarians, scientist and researchers around the world to find solutions to optimize animal healthcare.

###

If you would like more information about this topic, please contact Brian Kanke at brian@zoopharmadynamics.com or visit www.zoopharmadynamics.com.